AEBI vs VRTX · P/E 112, rev $1.53B vs P/E 30, rev $3.33B
Aebi Schmidt Holding AG - Common Stock (AEBI) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Aebi Schmidt Holding AG - Common Stock (AEBI) is a farm & heavy construction machinery company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported AEBI revenue for 2025-12-31 was $1.53B. Net income was $9.7M. Revenue was up 40.6% from 2024-12-31 to 2025-12-31. AEBI currently screens at market cap $958.8M and trailing P/E 112.5.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
AEBI currently screens at market cap $958.8M and trailing P/E 112.5. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the AEBI and VRTX stock pages for the full models.
Not investment advice.